8-K: Acadia Healthcare Q2 2026 Earnings: Revenue Flat, Profit Declines

Acadia Healthcare reported second quarter 2026 results with revenue flat year-over-year, while net income and adjusted EBITDA saw significant decreases due to increased liability reserves and timing of supplemental payments.

Summary

• Acadia Healthcare announced its second quarter 2026 financial results, reporting total revenue of $865.8 million, which was approximately flat compared to the prior year.
• Net income attributable to Acadia was $10.9 million ($0.12 per diluted share), a significant decrease from $30.1 million ($0.33 per diluted share) in the second quarter of 2025.
• Adjusted net income attributable to Acadia was $35.1 million ($0.38 per diluted share), down from $74.8 million ($0.83 per diluted share) in the prior year.
• Adjusted EBITDA was $149.2 million, a decrease from $201.8 million in the prior-year period.
• The company added 240 licensed beds during the quarter from newly constructed facilities.
• Operating cash flows were $162.1 million, an increase from $133.5 million in the prior-year period.
• Full-year 2026 guidance was updated, with revenue projected between $3.40 to $3.45 billion and Adjusted EBITDA between $590 to $615 million.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to the significant decline in net income and Adjusted EBITDA, despite flat revenue and increased operating cash flow. The increase in liability reserves is a key concern.

Positives

• Operating cash flows increased to $162.1 million from $133.5 million in the prior-year period.
• 240 licensed beds were added during the second quarter through new facilities.
• The company opened two new joint venture facilities and two new CTC locations.
• Full-year revenue guidance was slightly increased at the lower end ($3.40 billion vs $3.37 billion).
• Full-year Adjusted EBITDA guidance range remains strong ($590-$615 million).

Negatives

• Net income attributable to Acadia decreased by 64% to $10.9 million from $30.1 million.
• Adjusted net income attributable to Acadia decreased by 53% to $35.1 million from $74.8 million.
• Adjusted EBITDA decreased by 26% to $149.2 million from $201.8 million.
• Total revenue was flat year-over-year at $865.8 million.
• Specialty treatment facility revenue decreased by 8.4% to $133.5 million.
• Total operating expenses increased by 7.3% to $727.6 million.

Risks

• Potential difficulties in successfully integrating operations of acquired facilities or realizing expected benefits from expansions and transactions.
• Potential reductions in payments from government and commercial payors due to changes in Medicaid financing mechanisms (OBBBA).
• Risk of patient incidents, governmental investigations, litigation, and adverse regulatory actions.
• Risk of not generating sufficient cash from operations to service debt and meet working capital and capital expenditure requirements.
• Potential disruptions to information technology systems or adverse impacts from cybersecurity incidents.
• Increased costs relating to labor, supply chain, and other expenditures.
• Changes in competition and client preferences.
• General economic or industry conditions that may prevent realization of expected benefits from business strategies.

Future Outlook

Acadia updated its full-year 2026 guidance, projecting revenue between $3.40 to $3.45 billion and Adjusted EBITDA between $590 to $615 million. Operating cash flow is expected to be between $350 to $400 million, with capital expenditures between $235 to $255 million.

Management Comments

• "Acadia delivered solid results in the second quarter that were driven by our continued focus on disciplined operational execution and providing quality care for our patients."
• "We made significant progress on our key priorities during the second quarter, including opening two new facilities with JV partners, continuing to ramp occupancy at our new facilities opened over the last few years, and generating strong free cash flow."
• "We are well-positioned for additional progress in the second half of the year as we build upon our leadership position in the behavioral healthcare industry and continue expanding access to quality care for our patients."

Industry Context

StockSavvy.ai notes that Acadia Healthcare's results reflect challenges common in the behavioral healthcare sector, including managing liability reserves and navigating complex supplemental payment programs. The company's focus on expanding capacity through new facilities and joint ventures aligns with industry trends of increasing demand for behavioral health services.

Comparison to Industry Standards

• No direct comparisons to specific global benchmarks or named competitors were provided in the filing.
• The filing focuses on Acadia's internal performance metrics and year-over-year comparisons.

Legal Proceedings

• The filing mentions ongoing government investigations and litigation as potential risks.
• A $28.6 million adjustment to professional and general liability (PLGL) reserves for expected settlements of certain claims from the 2025 policy year was noted.

Stakeholder Impact

• Shareholders: Potential negative impact due to decreased profitability and earnings per share.
• Employees: Increased focus on operational execution and quality care may impact workload and performance expectations.
• Customers: Continued expansion of facilities and services aims to improve access to care.
• Creditors: Net leverage ratio was 4.1x Adjusted EBITDA, which may be a point of monitoring for lenders.

Next Steps

• Continue ramping occupancy at newly opened facilities.
• Build upon leadership position in the behavioral healthcare industry.
• Continue expanding access to quality care for patients.
• Focus on disciplined operational execution.
• Hold conference call on July 29, 2026, to discuss results.

Key Dates

Recommendation

While revenue was flat and operating cash flow improved, the significant drop in net income and Adjusted EBITDA, largely due to increased liability reserves, warrants caution. The updated guidance provides some clarity, but the underlying profitability concerns suggest a 'hold' rating until operational improvements and reserve management stabilize.

Keywords

behavioral healthcare, inpatient psychiatric, treatment facilities, revenue, EBITDA, earnings, guidance, cash flow